Norfoalk
Fiche investisseur | Builders Republic
À propos
Norfoalk is the private investment holding (Family Office) of entrepreneur Jean-Guillaume Lafay. Following the successful exit of his biotech company, Mablink Bioscience, to Eli Lilly in 2023, Lafay established Norfoalk to manage his personal investments, focusing primarily on innovation in the healthcare and deeptech sectors.
Informations clés
- Type
- Family Office
- Stades
- Pre-Seed,Seed
- Secteurs
- Biotech,Healthcare
- Siège
- France
- Bureaux
- Lyon
- Focus géographique
- France
- Lead / Follow
- Follower
- Fondé en
- 2020
Investissements notables en France
Axoltis Pharma
Points différenciants
Sector Specialist